Find and Pitch Jounalists, Get Your Story Covered

Tags: autism spectrum disorder ,leukemia,cancer risk and autism,neurodevelopmental disorders leukemia cancer acute promyelocytic leukemia bone marrow biopsy

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis - 23 days ago Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - 4 months ago FDA Panel Endorses Imetelstat for MDS-Related Anemia - 11 months ago FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia - 11 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 12 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - about 1 year ago
2	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma - about 1 month ago Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation - about 1 month ago Mezigdomide Combinations Show Promise in Multiple Myeloma - about 1 month ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 7 months ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 7 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - about 1 year ago
3	<em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	What Drives Myeloid Cell Responses to Disease - about 2 months ago
4	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - about 2 months ago STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients - about 1 year ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More - about 2 months ago
6	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - about 2 months ago Arcellx to present positive data on multiple myeloma treatments - 3 months ago
7	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Study paints clearer picture of disadvantaged leukemia patients’ struggle to get bone marrow transplants - about 2 months ago
8	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL - about 2 months ago FDA Approves Earlier Use of CAR-T Products for Myeloma - 10 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - about 1 year ago MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia - about 1 year ago Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials - about 1 year ago Completely Oral Regimen Effective, Feasible in APL - about 1 year ago
9	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	FDA Investigating Blood Cancer Risk With Gene Therapy Skysona - 2 months ago
10	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Final Thoughts - 2 months ago Impact of Transplant Eligibility on Treatment Selection - 4 months ago

Journalists covering myeloid leukemia